


Jubiglim M 1 Tablet PR
Manufacturer
Jubilant Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Key Information
Short Description
Jubiglim M 1 Tablet PR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Dosage Form
Tablet PR
Introduction
Jubiglim M 1 Tablet PR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Use it as advised by your doctor or check the label for directions before use. Jubiglim M 1 Tablet PR is to be taken with food.
Safety Information
Side Effects
Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea vomiting and stomach pain as Jubiglim M 1 Tablet PR may cause a rare but serious condition called lactic acidosis
Alcohol Warning
It is unsafe to consume alcohol with Jubiglim M 1 Tablet PR.
Breastfeeding Warning
Jubiglim M 1 Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Jubiglim M 1 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Jubiglim M 1 Tablet PR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Quick Tips
Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Jubiglim M 1 Tablet PR may cause a rare but serious condition called lactic acidosis
Related Medicines

Gepride M-1 Tablet

Geminor M 1 Tablet PR

Zoryl-M 1 Tablet

Glycomet-GP 1 Tablet

Obimet GX 1 Tablet

K-Glim-M 1mg Tablet

Glyree-M 1 Tablet

Glimisave M1 Tablet

Jubiglim M 1 Tablet PR

Glador M1 Tablet
Frequently asked questions
What are the recommended storage conditions for Jubiglim M 1 Tablet PR?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of unused medication.
Can the use of Jubiglim M 1 Tablet PR lead to lactic acidosis?
Yes, using Jubiglim M 1 Tablet PR can increase the risk of lactic acidosis. It is a serious medical condition caused by excessive lactic acid in the blood (also known as MALA). This side effect is linked to the use of metformin and may be more common in patients with pre-existing kidney disease, older age, or heavy alcohol consumption. If you experience symptoms such as muscle pain or weakness, dizziness, tiredness, cold hands and feet, difficulty breathing, nausea, vomiting, stomach pain, or a slow heart rate, immediately discontinue Jubiglim M 1 Tablet PR and consult your doctor.
What is Jubiglim M 1 Tablet PR?
Jubiglim M 1 Tablet PR is a combination of two medicines: Glimepiride and Metformin. This combination is used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken alongside proper diet and exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas, while metformin reduces glucose production in the liver and enhances insulin sensitivity. This combination is not recommended for individuals with type 1 DM.
What are the possible side effects of Jubiglim M 1 Tablet PR?
Common side effects include hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache. Jubiglim M 1 Tablet PR can also cause rare but serious side effects such as lactic acidosis. On long-term use, it may lead to Vitamin B12 deficiency.
Can the use of Jubiglim M 1 Tablet PR lead to Vitamin B12 deficiency?
Yes, Jubiglim M 1 Tablet PR can cause Vitamin B12 deficiency on long-term use. It interferes with the absorption of Vitamin B12 in the stomach. Untreated, this may lead to anemia, nerve problems (tingling and numbness in hands and feet), weakness, urinary problems, changes in mental status, and difficulty maintaining balance (ataxia). To minimize this risk, some healthcare providers recommend supplementing Vitamin B12 from external sources at least once every year.
Can the use of Jubiglim M 1 Tablet PR cause hypoglycemia?
Yes, using Jubiglim M 1 Tablet PR can contribute to hypoglycemia (low blood sugar levels). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. These symptoms often occur when you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications simultaneously with Jubiglim M 1 Tablet PR. Regularly monitoring blood sugar levels is crucial in this case. Always carry a source of quick sugar like glucose tablets, honey, or fruit juice with you.
Is it safe to drink alcohol while taking Jubiglim M 1 Tablet PR?
No, alcohol consumption should be avoided when taking Jubiglim M 1 Tablet PR. Combining these two substances may lower blood sugar levels and increase the risk of hypoglycemia (low blood sugar). It can also contribute to a higher chance of lactic acidosis.